Indianapolis church sues JPMorgan over investment choices

Church alleges the firm steered it into risky, costly and unsuitable investments. It lost $13 million.
AUG 14, 2014
JPMorgan Chase & Co. is facing allegations it inappropriately steered clients into proprietary and underperforming funds and other investments. A lawsuit filed this week by leaders of the Christ Church Cathedral in Indianapolis comes after several news reports, citing anonymous sources, said the Securities and Exchange Commission is investigating the bank's subsidiaries for possible conflicts of interest in its mutual fund sales. The church's 50-page complaint, filed Wednesday in the U.S. District Court in Indianapolis, alleges the New York-based bank caused the church's trusts to lose some $13 million in value because of JPMorgan's decision to purchase 177 investment products “because they produced the highest revenues to JPMorgan, to the detriment of Christ Church.” The complaint said the proprietary products comprised between 68% and 85% of the Church's investment portfolio. A spokeswoman for New York-based JPMorgan, Kristen Chambers, declined to comment. A spokeswoman for the SEC, Judith A. Burns, also declined to comment. The church, founded in 1837 and a beneficiary of the family fortune of the pharmaceutical giant Eli Lilly & Co., was a client of JPMorgan and its Private Wealth Management division. The products purchased on behalf of the church included private equity and hedge funds, managed accounts, cash sweep accounts and mutual funds “so heavily burdened with expenses and fees that they were doomed to fail to perform” between 2004 and 2013, according to the complaint. The church's assets declined to $31.6 million in 2013 from $39.2 million before 2008, the complaint said, pointing to millions earned by the firm for cross-selling investment products.

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor